Reuters
1/2
Doses of the Chinese Sinopharm vaccine against the coronavirus disease (COVID-19) are seen at the Biblioteka kod Milutina restaurant in Kragujevac, Serbia, May 4, 2021. REUTERS/Marko Djurica/File Photo
Read More
BEIJING, June 29 (Reuters) - Many countries from China to Indonesia and Brazil rely heavily on Chinese vaccines to inoculate their people against COVID-19, but there are growing concerns about whether they provide enough protection against the Delta variant, first identified in India.
Below are views from China s health experts about the effectiveness of home-grown vaccines against the Delta, which is becoming the globally dominant variant, and virus preventive measures China is taking.
Guangzhou
Guangdong
China
India
United-kingdom
Shenzhen
Brazil
Beijing
Dongguan
Guizhou
Zhong-nanshan
Hunan